JP2003180355A - Method for producing l-amino acid - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for producing L-amino acids, such as L-lysine or L-glutamic acid, through a fermentation process which is more improved than ever, and to provide strains used for the method. <P>SOLUTION: This coryneform bacterium is obtained by introducing a gene which codes enolase into the coryneform bacterium having ability for producing the L-amino acids, such as the L-lysine or the L-glutamic acid, so that enolase activity of the bacterium is enhanced. Thus, the bacterium is improved in the ability for producing the L-amino acids. The bacterium is utilized in the method for producing the amino acids. <P>COPYRIGHT: (C)2003,JPO

Description

Detailed Description of the Invention

[0001]

TECHNICAL FIELD The present invention relates to an L-based fermentation method.
The present invention relates to a method for producing an amino acid, particularly L-lysine and L-glutamic acid. L-lysine is widely used as a feed additive and the like, and L-glutamic acid is widely used as a raw material for seasonings and the like.

[0002]

2. Description of the Related Art Conventionally, L-amino acids such as L-lysine and L-glutamic acid have been fermented by a coryneform bacterium belonging to the genus Brevibacterium or Corynebacterium having the ability to produce these L-amino acids. It is manufactured industrially. For these coryneform bacteria, strains isolated from nature or artificial mutants of these strains are used in order to improve productivity.

Further, various techniques have been disclosed for increasing the L-amino acid-producing ability by enhancing the L-amino acid biosynthetic enzyme by recombinant DNA technology. For example, in coryneform bacteria having L-lysine-producing ability, a gene encoding aspartokinase in which feedback inhibition by L-lysine and L-threonine is released (mutant lysC), dihydrodipicolinate reductase gene (dapB), Dihydrodipicolinate synthase gene (dapA), diaminopimelate decarboxylase gene (lysA) gene, and diaminopimelate dehydrogenase gene (ddh) (WO96 / 40934), lysA and ddh
(JP-A-9-322774), lysC, lysA and phosphoenolpyruvate carboxylase gene (ppc) (JP-A-1-322774).
0-165180), mutant lysC, dapB, dapA, lysA and aspartate aminotransferase gene (aspC).
It is known that the introduction of (JP-A-10-215883) improves the L-lysine-producing ability of the bacterium.

In Escherichia bacteria, da
Sequential enhancement of pA, mutant lysC, dapB, diaminopimelate dehydrogenase gene (ddh) (or tetrahydrodipicolinate succinylase gene (dapD) and succinyldiaminopimelate deacylase gene (dapE)) improves L-lysine productivity Is known (WO 95/16042). In WO 95/16042, tetrahydrodipicolinate succinylase is erroneously described as succinyldiaminopimelate transaminase. On the other hand, in a bacterium of the genus Corynebacterium or genus Brevibacterium, the introduction of a gene encoding a citrate synthase derived from Escherichia coli or Corynebacterium glutamicum was effective for enhancing the L-glutamic acid-producing ability. Has been reported (Japanese Patent Publication No. 7-121228). Further, Japanese Patent Application Laid-Open No. 61-268185 discloses a cell having a recombinant DNA containing a glutamate dehydrogenase gene derived from a bacterium belonging to the genus Corynebacterium. Further, Japanese Patent Laid-Open No. 63-214189 discloses a technique for increasing the L-glutamic acid production ability by enhancing the glutamate dehydrogenase gene, the isocitrate dehydrogenase gene, the aconitate hydratase gene, and the citrate synthase gene. Has been done.

However, the structure of the gene encoding enolase has not been reported in coryneform bacteria, and the use of the gene encoding enolase in breeding coryneform bacteria has not been known.

DISCLOSURE OF THE INVENTION It is an object of the present invention to provide a method for producing L-amino acids such as L-lysine or L-glutamic acid by a fermentation method which is further improved than before, and a strain used therefor. To do.

[0006]

Means for Solving the Problems As a result of intensive studies to solve the above problems, the present inventors have introduced a gene encoding enolase into a coryneform bacterium and amplifying the enolase activity. It was found that the production amount of L-lysine or L-glutamic acid can be increased, and the present invention has been completed. That is, the present invention is as follows.

(1) A coryneform bacterium having enhanced enolase activity in cells and L-amino acid-producing ability. (2) The coryneform bacterium of (1), wherein the L-amino acid is selected from L-lysine, L-glutamic acid, L-threonine, L-isoleucine, and L-serine. (3) The coryneform bacterium according to (1) above, wherein the enhancement of the enolase activity is caused by increasing the copy number of a gene encoding enolase in the bacterial cell. (4) The coryneform bacterium of (3), wherein the gene encoding the enolase is derived from a bacterium belonging to the genus Escherichia. (5) The method of culturing the coryneform bacterium according to any one of (1) to (4) above in a medium to produce and accumulate L-amino acid in the culture, and collecting the L-amino acid from the culture. And a method for producing an L-amino acid. (6) The method according to (5), wherein the L-amino acid is selected from L-lysine, L-glutamic acid, L-threonine, L-isoleucine and L-serine.

[0008]

BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be described in detail below.

<1> Coryneform bacterium of the present invention The coryneform bacterium of the present invention has L-amino acid-producing ability,
It is a coryneform bacterium with enhanced enolase activity in cells. Examples of L-amino acids include L-lysine, L-glutamic acid, L-threonine, L-isoleucine and L-serine. Among these, L-lysine and L-
Glutamic acid is preferred. Hereinafter, the embodiment of the present invention will be described mainly for a coryneform bacterium having L-lysine-producing ability or L-glutamic acid-producing ability. Can be similarly applied to those located downstream.

The coryneform bacteria referred to in the present invention include Bergey's Manual of Determinative Baciology.
teriology) 8th edition pp. 599 (1974), a group of microorganisms that are aerobic, gram-positive, non-acidic, non-sporulating rods, and are conventionally classified as Brevibacterium. However, it contains bacteria that have been integrated as Corynebacterium (Int. J. Syst. Bacterio
l., 41, 255 (1981)), and also Brevibacterium and Microbacterium which are closely related to the genus Corynebacterium. Examples of coryneform bacterial strains that are preferably used for the production of L-lysine or L-glutamic acid include:
For example, the following may be mentioned.

[0011]   Corynebacterium acetoside film ATCC13870   Corynebacterium acetoglutamicum ATCC15806   Corynebacterium carnae ATCC15991   Corynebacterium glutamicum ATCC13032   (Brevibacterium divaricatum) ATCC14020   (Brevibacterium lactofermentum) ATCC13869    (Corynebacterium Lilium) ATCC15990   (Brevibacterium flavum) ATCC14067   Corynebacterium meracecola ATCC17965   Brevibacterium saccharolyticum ATCC14066   Brevibacterium Inmario Film ATCC14068   Brevibacterium roseum ATCC13825   Brevibacterium thiogenitalis ATCC19240   Microbacterium Ammonia Philum ATCC15354   Corynebacterium thermoaminogenes AJ12340 (FERM BP-1539)

To obtain these, for example, American Type Culture Collection (American Type
Culture Collection, Address 12301 Parklawn Drive, Roc
kville, Maryland 20852, United States of America)
You can get more sales. That is, a registration number corresponding to each microorganism is given, and the registration number can be quoted to receive the sale. The registration number corresponding to each microorganism is listed in the American Type Culture Collection catalog. Also, AJ12340
The shares have been deposited under the Budapest Treaty at the Institute of Biotechnology, Industrial Technology Institute, Ministry of International Trade and Industry (Postal Code 305-8566, 1-3-1 Higashi, Tsukuba, Ibaraki, Japan).

In addition to the above strains, L-lysine or L-glutamic acid-derived L-derived from these strains
Mutant strains having amino acid-producing ability can also be used in the present invention. Such artificial mutant strains include the following.
S- (2-aminoethyl) -cysteine (hereinafter referred to as "AE
Abbreviated as "C") resistant mutant strain (for example, Brevibacterium lactofermentum AJ11082 (NRRL B-1147
0), Japanese Patent Sho 56-1914, Japanese Patent Sho 56-1915, Japanese Patent Sho 57-14
No. 157, Japanese Examined Japanese Patent No.
8-10075, Japanese Examined Sho 59-4993, Japanese Examined Sho 61-35840, Examined Sho 62-24074, Examined Sho 62-36673, Examined Hei 5-11958,
Japanese Patent Publication Nos. 7-112437 and 7-112438), mutants that require amino acids such as L-homoserine for their growth (Japanese Patent Publication Nos. 48-28078 and 56-6499), resistant to AEC , L-leucine, L-homoserine, L-proline, L-serine, L-arginine, L-alanine, L-
Variants requiring amino acids such as valine (US Patent No. 3708
395 and No. 3825472), DL-α-amino-ε-caprolactam, α-amino-lauryllactam, aspartic acid-analog, sulfa drugs, quinoids, L-lysine-producing mutant strains resistant to N-lauroylleucine, L-lysine-producing mutants showing resistance to oxaloacetate decarboxylase (decarboxylase) or respiratory enzyme inhibitors (JP-A-50-53588, JP-A-50-31093, JP-A-52-102498)
JP-A-53-9394, JP-A-53-86089, JP-A-55-97
83, JP-A-55-9759, JP-A-56-32995, JP-A-56-
39778, JP-B-53-43591, JP-B-53-1833), L-lysine-producing mutant strains requiring inositol or acetic acid (JP-A-55-9784, JP-A-56-8692), fluoropyrubin L- showing sensitivity to acids or temperatures above 34 ° C
Lysine-producing mutants (JP-A-55-9783, JP-A-53-86090)
No.), a production mutant strain of the genus Brevibacterium or Corynebacterium, which is resistant to ethylene glycol and produces L-lysine (US Pat. No. 4411997).

As a coryneform bacterium having L-threonine-producing ability, corynebacterium acetoacidophilum AJ12318 (FERM BP-1172) (US Pat. No. 5,188,94)
Brevibacterium flavum AJ121 is a coryneform bacterium capable of producing L-isoleucine.
49 (FERM BP-759) (see US Pat. No. 4,656,135) and the like.

<2> Amplification of Enolase Activity To amplify enolase activity in coryneform bacterial cells,
A gene fragment encoding enolase is ligated to a vector that functions in the bacterium, preferably a multicopy type vector to prepare a recombinant DNA, which is introduced into a coryneform bacterium capable of producing L-lysine or L-glutamic acid. And then transform. As a result of the increase in the copy number of the gene encoding enolase in the cells of the transformant, the enolase activity is amplified. Enolase is encoded by the eno gene in Escherichia coli.

As the enolase gene, either a coryneform bacterium gene or a gene derived from another organism such as Escherichia bacterium can be used. The nucleotide sequence of the Escherichia coli eno gene has already been revealed (Klein, M. et al., DNA Seq. 6, 315-355 (199
6 years), Genbank / EMBL / DDBJ accetion No. X82400), so using the primers prepared based on the nucleotide sequence, for example, the primers shown in SEQ ID NOS: 1 and 2 in the Sequence Listing,
PCR method using Escherichia coli chromosomal DNA as a template (PCR: polymerase chain reaction; White, TJ e
t al; Trends Genet. 5,185 (1989)), eno
Genes can be obtained. Genes encoding enolases of other microorganisms such as coryneform bacteria can be obtained in the same manner.

Chromosomal DNA can be obtained from bacteria that are DNA donors, for example, by the method of Saito and Miura (H. Saito and K. Mi).
ura Biochem. Biophys. Acta, 72, 619 (1963), Biotechnology Experiment Manual, Japan Society for Biotechnology, pages 97-98, Baifukan,
1992) and the like.

The gene encoding the enolase amplified by the PCR method is a vector DN capable of autonomously replicating in the cells of Escherichia coli and / or coryneform bacteria.
When the recombinant DNA is prepared by connecting to A and introduced into Escherichia coli cells, the subsequent operation becomes easy. As a vector capable of autonomously replicating in Escherichia coli cells, a plasmid vector is preferable, and a vector capable of autonomous replication in the cells of the host is preferable.
UC19, pUC18, pBR322, pHSG299, pHSG399, pHSG398, RS
F1010 etc. are mentioned.

Examples of the vector capable of autonomously replicating in the cells of coryneform bacteria include pAM330 (see JP-A-58-67699) and pHM1519 (see JP-A-58-77895). When a DNA fragment capable of autonomously replicating a plasmid in a coryneform bacterium is extracted from these vectors and inserted into the Escherichia coli vector, autonomous replication is possible in both Escherichia coli and a coryneform bacterium. Can be used as a so-called shuttle vector. Examples of such shuttle vectors include the following. The microorganisms carrying the respective vectors and the deposit numbers of the international depository institutions are shown in parentheses.

In order to prepare a recombinant DNA by ligating a gene encoding enolase with a vector functioning in coryneform bacterium, the vector is cleaved with a restriction enzyme that fits the end of the gene encoding enolase. Connection is T4
It is common to use a ligase such as a DNA ligase.

The recombinant DNA prepared as described above can be introduced into a coryneform bacterium by any of the transformation methods previously reported. For example, a method of treating recipient cells with calcium chloride to increase DNA permeability, as reported for Escherichia coli K-12 (Mandel, M. and Higa, A., J. Mol. Biol. , 53,159
(1970)), and a method of preparing competent cells from cells in the growth stage and introducing DNA as described for Bacillus subtilis (Duncan, CH, Wil.
son, GAand Young, FE, Gene, 1, 153 (1977)). Alternatively, cells of DNA-accepting bacteria, such as those known for Bacillus subtilis, actinomycetes and yeast, are brought into a protoplast or spheroplast in which the recombinant DNA is easily taken up, and the recombinant DNA is DNA.
Method of introducing into recipient bacteria (Chang, S. And Choen, SN, Mole
c. Gen. Genet., 168, 111 (1979); Bibb, MJ, Ward, J.
M. and Hopwood, OA, Nature, 274, 398 (1978); Hinnen,
A., Hicks, JBand Fink, GR, Proc. Natl. Acad. Sci.
USA, 75 1929 (1978)) can also be applied. The transformation method used in the examples of the present invention was the electric pulse method (Japanese Patent Laid-Open No.
207791).

Amplification of the enolase-encoding activity is carried out by synthesizing the gene encoding enolase into the chromosomal DNA of the host.
It can also be achieved by having multiple copies on top. In order to introduce the gene coding for enolase in multiple copies into the chromosomal DNA of a microorganism belonging to coryneform bacterium, homologous recombination is carried out by using a sequence existing in multiple copies in the chromosomal DNA as a target. Repetitive DNA and inverted repeats present at the ends of transposable elements can be used as the sequences present in multiple copies on the chromosomal DNA.
Alternatively, as disclosed in Japanese Patent Application Laid-Open No. 2-109985, it is also possible to mount a gene encoding enolase on a transposon and transfer it to introduce multiple copies onto chromosomal DNA. Either method increases the copy number of the gene encoding enolase in the transformant, resulting in amplification of enolase activity.

Amplification of enolase activity can be achieved by substituting a strong expression control sequence such as a promoter of a gene encoding enolase on chromosomal DNA or a plasmid with a strong one in addition to the above-described gene amplification ( See Japanese Patent Application Laid-Open No. 1-215280). For example,
lac promoter, trp promoter, trc promoter, tac promoter, P _{R of} lambda phage
Promoter, P _L promoter, and so forth are known as strong promoters. Substitution with these promoters enhances the expression of the gene encoding enolase, thereby amplifying the enolase activity.

[0024] In addition to the enolase activity, the coryneform bacterium of the present invention may have its enzymatic activity enhanced by enhancing other amino acid biosynthetic pathways or enzyme genes such as glycolytic pathways. For example, examples of genes that can be used for producing L-lysine include aspartokinase α subunit protein or β subunit protein in which synergistic feedback inhibition by L-lysine and L-threonine is substantially released. Gene encoding (WO94 / 25605
International Publication Pamphlet), wild-type phosphoenolpyruvate carboxylase gene derived from coryneform bacteria (JP-A-60-87788), gene encoding wild-type dihydrodipicolinate synthase derived from coryneform bacteria (Japanese Patent Publication No. 6-55149). Gazette) etc. are known.

Examples of genes that can be used for the production of L-glutamic acid include glutamate dehydrogenase (GDH, JP-A-61-268185), glutamine synthetase, glutamate synthase, and isocitrate dehydrogenase (JP-A-62-166890). No. JP-A-63-214189), aconitate hydratase (JP-A-62-294086), citrate synthase, pyruvate carboxylase (JP-A-60-877).
88, JP-A-62-55089), phosphoenolpyruvate carboxylase, phosphoenolpyruvate synthase, enolase, phosphoglyceromutase,
Phosphoglycerate kinase, glyceraldehyde-3
-Phosphate dehydrogenase, triose phosphate isomerase, fructose bisphosphate aldolase, phosphofructokinase (JP-A-63-102692), glucose phosphate isomerase and the like.

Furthermore, the activity of an enzyme that catalyzes a reaction that branches from the L-amino acid biosynthetic pathway of interest to produce a compound other than the L-amino acid may be decreased or lacking. For example, as an enzyme that catalyzes a reaction that branches from the L-lysine biosynthetic pathway to produce a compound other than L-lysine, there is homoserine dehydrogenase (WO 95 /
23864). In addition, as an enzyme that catalyzes a reaction that branches from the L-glutamic acid biosynthetic pathway to produce a compound other than L-glutamic acid, α-ketoglutarate dehydrogenase, isocitrate lyase, phosphate acetyltransferase, acetate kinase, acetohydroxy acid Synthase, acetolactate synthase, formate acetyltransferase, lactate dehydrogenase, glutamate decarboxylase, 1-pyrophosphate dehydrogenase, and the like.

Furthermore, by imparting a temperature-sensitive mutation to a coryneform bacterium capable of producing L-glutamic acid, a temperature-sensitive mutation for a biotin-inhibiting substance such as a surfactant, the biotin-inhibiting effect in a medium containing an excess amount of biotin. L-glutamic acid can be produced in the absence of a substance (see WO96 / 06180). Examples of such coryneform bacteria include Brevibacterium lactofermentum AJ13029 described in WO96 / 06180. AJ130
Twenty-nine shares were deposited at the Institute of Biotechnology, Institute of Biotechnology, Institute of Industrial Science with the deposit number FERM P-14501 on September 2, 1994,
It was transferred to an international deposit under the Budapest Treaty on August 1, 1995 and is given the deposit number FERM BP-5189.

In addition, a coryneform bacterium capable of producing L-lysine and L-glutamic acid is provided with a temperature-sensitive mutation to a biotin action-suppressing substance, whereby a biotin action-suppressing substance is contained in a medium containing an excess amount of biotin. L-lysine and L-glutamic acid can be co-produced in the absence of (see WO96 / 06180). Examples of such strains include Brevibacterium lactofermentum AJ12993 strain described in WO96 / 06180. The strain was deposited at the Institute of Biotechnology, Institute of Biotechnology, Institute of Industrial Science with the deposit number FERM P-14348 as of June 3, 1994, and was transferred to the international deposit under the Budapest Treaty on August 1, 1995 and deposited. It is numbered FERM BP-5188.

<3> Production of L-Amino Acid If a coryneform bacterium, which has an enolase activity and is capable of producing L-amino acid, is cultured in a suitable medium, the same L
-Amino acids accumulate in the medium. For example, when a coryneform bacterium having an enolase activity amplified and L-lysine acid-producing ability is cultured in a suitable medium, L-lysine is accumulated in the medium. Further, when coryneform bacteria having an enolase activity amplified and L-glutamic acid-producing ability are cultured in a suitable medium, L-glutamic acid is accumulated in the medium.

Further, when coryneform bacteria having an enolase activity amplified and capable of producing L-lysine and L-glutamic acid are cultured in a medium, L-lysine and L-glutamic acid are accumulated in the medium. When L-lysine and L-glutamic acid are simultaneously fermentatively produced, the L-lysine-producing bacterium may be cultivated under the L-glutamic acid-producing conditions, or L-lysine-producing coryneform bacterium and L-lysine-producing bacteria may be used. -Coryneform bacteria capable of producing glutamic acid may be mixed and cultured (JP-A-5-3793).

Using the microorganism of the present invention, L-lysine or L
The medium used for producing L-amino acids such as glutamic acid is a normal medium containing a carbon source, a nitrogen source, inorganic ions and, if necessary, other organic micronutrients. As the carbon source, glucose, lactose, galactose, fructose, sucrose, molasses, carbohydrates such as starch hydrolysate, alcohols such as ethanol and inositol, organic acids such as acetic acid, fumaric acid, citric acid, and succinic acid. Can be used.

As the nitrogen source, ammonium sulfate, ammonium nitrate, ammonium chloride, ammonium phosphate, inorganic ammonium salts such as ammonium acetate, ammonia, peptone, meat extract, yeast extract, yeast extract,
Organic nitrogen such as corn steep liquor and soybean hydrolyzate, ammonia gas, and ammonia water can be used.

As the inorganic ions, potassium phosphate, magnesium sulfate, iron ions, manganese ions and the like are added in small amounts. As the organic micronutrients, it is desirable to contain required substances such as vitamin B ₁ or yeast extract in an appropriate amount as necessary.

The culture is preferably carried out for 16 to 72 hours under aerobic conditions such as shaking culture and aeration and stirring culture. The culture temperature is controlled at 30 ° C to 45 ° C and the pH during culture is controlled at 5-9. To do. Inorganic or organic acidic or alkaline substances, ammonia gas, etc. can be used for pH adjustment.

Collection of L-amino acids from the fermentation broth can be carried out in the same manner as in ordinary L-amino acid production methods. For example, L-lysine can be usually collected by combining an ion exchange resin method, a precipitation method and other known methods. Further, the method for collecting L-glutamic acid may be carried out by a conventional method, for example, an ion exchange resin method,
A crystallization method or the like can be used. Specifically, L-glutamic acid is adsorbed and separated by an anion exchange resin, or
Alternatively, neutralization crystallization may be performed. When producing both L-lysine and L-glutamic acid, it is not necessary to separate these amino acids from one another if they are used as a mixture.

[0036]

EXAMPLES The present invention will be described in more detail below with reference to examples.

<1> Cloning of eno gene of Escherichia coli JM109 strain The nucleotide sequence of the eno gene of Escherichia coli has already been clarified (Klein, M. et al., DNA Seq. 6, 315-
355 (1996), Genbank / EMBL / DDBJ accetion No.X8240
0). The primers shown in SEQ ID NOS: 1 and 2 in the Sequence Listing were synthesized based on the reported nucleotide sequence, and Escherichia
The pyruvate dehydrogenase gene was amplified by PCR using the chromosomal DNA of Escherichia coli JM109 as a template.

Among the synthesized primers, SEQ ID NO: 1 is
It corresponds to the sequence from the 1st to 24th base in the nucleotide sequence of the eno gene described in Genbank / EMBL / DDBJ accetion No. X82400. SEQ ID NO: 2 is from the 2089th to 2066th bases. Equivalent to.

Chromosomal DN of Escherichia coli JM109 strain
Preparation of A was carried out by a conventional method (Biotechnology Experiment Book, edited by Japan Society for Biotechnology, pp. 97-98, Baifukan, 1992). Also,
For the PCR reaction, the standard reaction conditions described on page 185 of the PCR method front line (Takeo Sekiya et al., Edited by Kyoritsu Shuppan, 1989) were used.

After purifying the generated PCR product by a conventional method,
After ligation with SmaI-cut plasmid pHC4 using a ligation kit (Takara Shuzo), transformation was performed using Escherichia coli JM109 competent cells (Takara Shuzo), and chloramphenicol 30 μg / ml
L medium containing 10 g / L of bactotryptone, 5 g / L of bacto yeast extract, 5 g / L of NaCl, 15 g / L of agar, pH 7.
After applying to 2) and culturing overnight, the white colonies that appeared were picked up and single colonies were separated to obtain a transformant. Extract the plasmid from the obtained transformant and use it as a vector.
A plasmid pHC4pps to which the eno gene was bound was obtained.

Escherichia coli which retains pHC4 is named as a private number AJ12617, 199.
On April 24, 1991, the Ministry of International Trade and Industry, Institute of Industrial Science and Technology, Institute of Biotechnology, Industrial Technology (Postal code 305-8566, 1-3-1 Higashi, Tsukuba, Ibaraki, Japan), with the contract number FERM P-12215
And was transferred to an international deposit under the Budapest Treaty on August 26, 1991, with the deposit number FERM B.
P-3532 is added.

Next, in order to confirm that the cloned DNA fragment encodes a protein having an enolase activity, the enolase activity of the JM109 strain and the JM109 strain carrying pHC4eno was analyzed by Bucher, T.,
It was measured by the method described in Meth. Enzymol. 1, 427-435 (1955). As a result, JM1 retaining pHC4eno
The 09 strain exhibited an enolase activity approximately 15 times that of the JM109 strain that does not retain pHC4eno, confirming that the eno gene was expressed.

<2> Introduction of pHC4eno into the L-glutamic acid-producing strain of coryneform bacterium and L-glutamic acid-producing Brevibacterium lactofermentum AJ13029 by the electric pulse method (see Japanese Patent Laid-Open No. 2-207791) for plasmid pHC4eno. The resulting transformant was obtained. Using the obtained transformant AJ13029 / pHC4eno, L-
The culture for producing glutamic acid was performed as follows.
The cells of the AJ13029 / pHC4eno strain obtained by culturing in a CM2B plate medium containing 5 μg / ml of chloramphenicol were
An L-glutamic acid-producing medium having the following composition containing μg / ml of chloramphenicol was inoculated, shake-cultured at 31.5 ° C., and shake-cultured until the sugar in the medium was consumed.
The resulting culture was inoculated into a medium of the same composition in an amount of 5%,
Shaking culture was carried out at ℃ until the sugar in the medium was consumed. As a control, the strain AJ13029 of the genus Corynebacterium was transformed by the electric pulse method with the plasmid pHC4 capable of autonomous replication in the bacterium of the genus Corynebacterium, which was obtained in the same manner as above.

[L-glutamic acid-producing medium] The following components (in 1 L) were dissolved, adjusted to pH 8.0 with KOH, and then at 115 ° C for 15
Sterilize for minutes. Glucose _{150g KH 2 PO 4 2g MgSO 4} · 7H 2 O 1.5g FeSO 4 · 7H 2 O 15mg MnSO 4 · 4H 2 O 15mg soy protein hydrolyzate 50ml biotin 2mg thiamine hydrochloride 3mg

After completion of the culturing, the accumulated amount of L-glutamic acid in the culture broth was measured by Asahi Kasei Kogyo Biotech Analyzer AS.
It was measured by -210. The results at this time are shown in Table 1.

[0046]

[Table 1]

<3> Introduction of pHC4eno into L-lysine producing strain of coryneform bacterium and L-lysine producing Brevibacterium lactofermentum AJ11082 by the electric pulse method (see Japanese Patent Laid-Open No. 2-207791) for plasmid pHC4eno. The resulting transformant was obtained. Using the obtained transformant AJ11082 / pHC4eno, L-
Culture for lysine production was performed as follows. 5 μg / m
5 μg / ml of AJ11082 / pHC4eno strain obtained by culturing in a CM2B plate medium containing 1 chloramphenicol
Was inoculated into the L-lysine production medium having the following composition containing chloramphenicol and cultured at 31.5 ° C. with shaking until the sugar in the medium was consumed. As a control, the strain AJ11082 of the genus Corynebacterium was transformed by the electric pulse method with the plasmid pHC4 capable of autonomous replication in the bacterium of the genus Corynebacterium already obtained, and cultured in the same manner as above.

Brevibacterium lactofermentum AJ11082 was prepared on the 18th of June, 1979.
Research Service Culture Collection (Agri
cultural research service culture collection) and has been deposited with the deposit number NRRL B-11470.

[L-lysine production medium] The following components (in 1 L) other than calcium carbonate were dissolved, adjusted to pH 8.0 with KOH, sterilized at 115 ° C for 15 minutes, and then dry heat-sterilized calcium carbonate was added. Add 50 g. Glucose 100 g (NH ₄ ) ₂ SO ₄ 55 g KH ₂ PO ₄ 1 g MgSO ₄ / 7H ₂ O 1 g biotin 500 μg thiamine 2000 μg FeSO ₄ / 7H ₂ O 0.01 g MnSO ₄ / 7H ₂ O 0.01 g nicotinamide 5 mg protein hydrolyzate (bean concentrate) 30 ml calcium carbonate 50 g

After completion of the culturing, the amount of L-lysine accumulated in the culture broth was measured as Biotech Analyzer AS-21 manufactured by Asahi Kasei Corporation.
It was measured by 0. The results at this time are shown in Table 2.

[0051]

[Table 2]

<4> L-lysine and L- of coryneform bacterium
Introduction of pHC4eno into a glutamic acid producing strain and Brevibacterium lactofermentum AJ12993 co-producing L-lysine and L-glutamic acid were transformed with the plasmid pHC4eno by the electric pulse method (see Japanese Patent Laid-Open No. 2-207791), and obtained. A transformed strain was obtained. Using the obtained transformant AJ12993 / pHC4eno, L-
Culturing for lysine and L-glutamic acid production was performed as follows. AJ12993 / pHC4en obtained by culturing in CM2B plate medium containing 5 μg / ml chloramphenicol
The strain strain o was inoculated into the L-lysine production medium containing 5 μg / ml of chloramphenicol and cultured at 31.5 ° C.
The culture temperature was shifted to 34 ° C. 12 hours after the culture was started, and the culture was performed with shaking until the sugar in the medium was consumed.
Corynebacterium bacterium AJ12993 as a control
A strain obtained by transforming the already obtained plasmid pHC4 capable of autonomous replication in a bacterium belonging to the genus Corynebacterium by the electric pulse method was cultured in the same manner as above.

After completion of the culture, L-lysine and L in the culture solution
-The amount of accumulated glutamic acid was measured by Biotech Analyzer AS-210 manufactured by Asahi Kasei. The results at this time are shown in Table 3.

[0054]

[Table 3]                                 Table 3 ───────────────────────────────────     Strain L-lysine production (g / L) L-glutamic acid production (g / L) ───────────────────────────────────   AJ12993 / pHC4 10.2 19.1   AJ12993 / pHC4eno 12.4 21.5 ───────────────────────────────────

[0055]

Industrial Applicability According to the present invention, the ability of coryneform bacteria to produce L-amino acids such as L-lysine or L-glutamic acid can be improved.

[0056]

[Sequence list]                             Sequence Listing

[0057] <110> Ajinomoto Co., Inc. <120> Method for producing L-amino acid <130> P-6640 <141> 1999-07-02 <160> 2 <170> PatentIn Ver. 2.0

[0058] <210> 1 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: primer for       amplifying Esherichia coli eno gene <400> 1 aactagtgac ttgaggaaaa ccta 24

[0059] <210> 2 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: primer for       amplifying Esherichia coli eno gene <400> 2 ttccaagtgc aaattgccgt atta 24

─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. ⁷ Identification code FI theme code (reference) C12P 13/08 C12P 13/14 A 13/14 13/06 // (C12P 13/06 C12R 1:15 C12R 1:15) C12P 13/08 (C12P 13/08 13/14 C12R 1:15) C12N 15/00 ZNAA (C12P 13/14 C12R 1:15) (72) Inventor Osamu Kurahashi Suzuki, Kawasaki-ku, Kanagawa Prefecture Suzuki Machi 1-1 Ajinomoto Co., Inc. Fermentation Technology Laboratory F-term (reference) 4B024 AA03 AA05 BA07 BA71 BA72 BA74 CA03 CA20 DA06 DA10 EA04 GA11 GA14 GA19 4B064 AE19 AE25 CA02 CA19 CC01 CC24 CD01 CD09 CD22 CD30 DA10 4B065 AA22X AA24X AA26A A26X AA26A AC15 AC16 BA02 BA03 BA25 BB03 BB15 BB20 BB27 BC01 BC02 BC03 BC26 CA17 CA27 CA41 CA43

Claims (6)

[Claims] 1. A coryneform bacterium having enhanced enolase activity in cells and L-amino acid-producing ability. 2. The L-amino acid is L-lysine or L-
Glutamic acid, L-threonine, L-isoleucine, L
-The coryneform bacterium of claim 1, selected from serine. 3. The coryneform bacterium according to claim 1, wherein the enolase activity is enhanced by increasing the copy number of a gene encoding enolase in the bacterial cell. 4. The coryneform bacterium according to claim 3, wherein the gene encoding the enolase is derived from a bacterium belonging to the genus Escherichia. 5. The coryneform bacterium according to any one of claims 1 to 4 is cultured in a medium, L-amino acids are produced and accumulated in the culture, and the L-amino acids are collected from the culture. A method for producing an L-amino acid, which comprises: 6. The L-amino acid is L-lysine or L-
Glutamic acid, L-threonine, L-isoleucine, L
-The method of claim 5 selected from serine.